CONTROLLED-RELEASE NANOPARTICULATE COMPOSITIONS

Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel co...

Jain, Rajeev A，J Swanson，R Hontz，... - US

Nanoparticulate and controlled release compositions comprising cefditoren

Rekhi, Gurvinder SinghJenkins, Scott A.Liversidge, GaryUSUS7825087 Apr 12, 2006 Nov 2, 2010 Elan Pharma International Limited Nanoparticulate and controlled release compositions comprising cyclosporine...

JG Devane，P Stark，NMN Fanning，... - US

NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2 FIELD OF INVENTION

NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2 FIELD OF INVENTION(75) Inventors: John G. Devane, Barrymore Publication Classification ...

N Fanning

Time-release agent containing poorly soluble agent such as a drug

Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which fu...

J Swanson，RA Jain，R Hontz，...

Preparation and Characterization of Modified Release Nanoparticles Containing Cloperastine Hydrochloride Using Solvent Evaporation Method

release of Cloperastine hydrochloride and could be used as effective nanoparticulate formulations for controlled release drug delivery of Cloperastine ...

MSM Ameen - 《Journal of Nanostructures》

Photocatalytic Nanoparticulate ZrxTi1‐xO2 Coatings with Controlled Homogeneity of Elemental Composition

The mixed oxide ZrxTi1﹛O2 nanoparticulate photocatalysts of different compositions (0≤x≤1) were prepared via solゞel method in a rapid micromixing react...

K Cheng，K Chhor，JP Passarello，... - 《Chemistryselect》

HEAVY METAL- AND ODOUR-FREE NANOPARTICULATE COMPOSITIONS

said nanoparticulate composition by polymerization induced self-assembly (PISA) via non- transition-metal catalysed controlled radical polymerization (NTMC-CRP)....

G Atsushi，S Jit，L Xiao，...

NANOPARTICULATE CLOPIDOGREL FORMULATIONS

The present invention is directed to compositions comprising a nanoparticulate clopidogrel, or a salt or derivative thereof, having improved bioavailability. The nanoparticulate clopidogrel particles of the composition have an effective ...

JENKINS SCOTT，LIVERSIDGE GARY G.